Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Shanghai Jiao Tong University · Renji Hospital · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
550
total citations
- FWCI
- 17.43
- Percentile
- 100%
- References
- 44
Citations per year
Authors
15- HYHan YaoCorresponding
Shanghai Jiao Tong University, Renji Hospital, State Key Laboratory of Oncogene and Related Genes
- JLJiang Lan
Sichuan University, State Key Laboratory of Biotherapy
- CLChushu Li
Shanghai Jiao Tong University, Renji Hospital, State Key Laboratory of Oncogene and Related Genes
- HSHubing Shi
Sichuan University, State Key Laboratory of Biotherapy
- JBJean‐Philippe Brosseau
The University of Texas Southwestern Medical Center
Topics & keywords
Topics
Keywords
- Palmitoylation
- PD-L1
- Cancer research
- Cell biology
- Programmed cell death
- T cell
- Cancer cell
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.